Zhao GJ - Search Results

1

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Filippi M, et al. Among authors: zhao gj. Neurology. 1995 Feb;45(2):255-60. doi: 10.1212/wnl.45.2.255. Neurology. 1995. PMID: 7854522 Clinical Trial.

2

Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis.

Whitaker JN, Kachelhofer RD, Bradley EL, Burgard S, Layton BA, Reder AT, Morrison W, Zhao GJ, Paty DW. Whitaker JN, et al. Among authors: zhao gj. Ann Neurol. 1995 Oct;38(4):625-32. doi: 10.1002/ana.410380411. Ann Neurol. 1995. PMID: 7574459 Clinical Trial.

3

Effect of interferon beta-1b in MS: assessment of annual accumulation of PD/T2 activity on MRI. UBC MS/MRI Analysis Group and the MS Study Group.

Zhao GJ, Koopmans RA, Li DK, Bedell L, Paty DW. Zhao GJ, et al. Neurology. 2000 Jan 11;54(1):200-6. doi: 10.1212/wnl.54.1.200. Neurology. 2000. PMID: 10636148 Clinical Trial.

4

The use of MRI as an outcome measure in clinical trials.

Li DK, Li MJ, Traboulsee A, Zhao G, Riddehough A, Paty D. Li DK, et al. Adv Neurol. 2006;98:203-26. Adv Neurol. 2006. PMID: 16400836 Review.

5

T2 hyperintensities: findings and significance.

Li DK, Zhao G, Paty DW. Li DK, et al. Neuroimaging Clin N Am. 2000 Nov;10(4):717-38 ,ix. Neuroimaging Clin N Am. 2000. PMID: 11359721 Review.

6

Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss.

Moore GR, Laule C, Mackay A, Leung E, Li DK, Zhao G, Traboulsee AL, Paty DW. Moore GR, et al. J Neurol. 2008 Nov;255(11):1802-11. doi: 10.1007/s00415-008-0002-z. Epub 2008 Sep 24. J Neurol. 2008. PMID: 18821049

7

Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.

Paty DW, Li DK, Oger JJ, Kastrukoff L, Koopmans R, Tanton E, Zhao GJ. Paty DW, et al. Among authors: zhao gj. Ann Neurol. 1994;36 Suppl:S95-6. doi: 10.1002/ana.410360721. Ann Neurol. 1994. PMID: 8017896

8

Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis. The MS Study Group.

Zhao GJ, Li DK, Wolinsky JS, Koopmans RA, Mietlowski W, Redekop WK, Riddehough A, Cover K, Paty DW. Zhao GJ, et al. J Neuroimaging. 1997 Jan;7(1):1-7. doi: 10.1111/jon1997711. J Neuroimaging. 1997. PMID: 9038425 Clinical Trial.

9

Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.

Li DK, Zhao GJ, Paty DW; University of British Columbia MS/MRI Analysis Research Group. The SPECTRIMS Study Group. Li DK, et al. Among authors: zhao gj. Neurology. 2001 Jun 12;56(11):1505-13. doi: 10.1212/wnl.56.11.1505. Neurology. 2001. PMID: 11402107 Clinical Trial.

10

The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis.

Koopmans RA, Li DK, Redekop WK, Zhao GJ, Palmer MR, Kastrukoff LF, Paty DW. Koopmans RA, et al. Among authors: zhao gj. J Neuroimaging. 1993 Jul;3(3):163-8. doi: 10.1111/jon199333163. J Neuroimaging. 1993. PMID: 10146223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters